Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BIIB - Week In Review: RemeGen Raises $410 Million In Shanghai IPO For mAb/Dual Therapies

BIIB - Week In Review: RemeGen Raises $410 Million In Shanghai IPO For mAb/Dual Therapies

Biogen Inc.
  • RemeGen, a Yantai biotech with a deep portfolio of antibody and dual therapies, completed a $410 million IPO on the Shanghai Star Exchange.
  • Nanjing Biosion out-licensed global rights (ex-China) to Pyxis Oncology for an immunotherapy aimed at solid tumor cancers in a $226 million agreement.
  • A few more updates on major deals/financings and trials/approvals in China.

For further details see:

Week In Review: RemeGen Raises $410 Million In Shanghai IPO For mAb/Dual Therapies
Stock Information
Company Name: Biogen Inc.
Stock Symbol: BIIB
Market: NASDAQ
Website: biogen.com
Menu
BIIB BIIB Quote BIIB Short BIIB News BIIB Articles BIIB Message Board
Get BIIB Alerts

News, Short Squeeze, Breakout and More Instantly...